M. Noguchi

Entire CD3ε, δ, and γ humanized mouse to evaluate human CD3–mediated therapeutics

K. Jishage, O. Ueda, J. Nezu, 2017, Scientific Reports.

Entire CD 3 ε , δ , and γ humanized mouse to evaluate human CD 3 – mediated therapeutics

O. Ueda, J. Nezu, M. Morita, 2017 .

Differentiation and maintenance of mast cells from CD34(+) human cord blood cells.

Tomoaki Inoue, H. Okabe, T. Yoshikubo, 2006, Experimental hematology.

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors

E. Elgabry, M. Aoki, Yukari Nishito, 2017, Science Translational Medicine.

Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974.

J. Nezu, T. Igawa, K. Hattori, 2019, Methods.